Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig

Human Gene Therapy

Volumn 7, Issue 12, 1996, Pages 1455-1463

  Guerette B ^a   Vilquin, J T ^a   Gingras, M ^a   Gravel, C ^b   Wood, K J ^c   Tremblay, J P ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TRANSFER; IMMUNITY; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; TRANSGENE;

EID: 0029790327     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.12-1455     Document Type: Article

References (59)

1. ACSADI, G., JANI, A., MASSIE, B., SIMONEAU, M., HOLLAND, P., BLASCHUK, K., and KARPATI, G. (1994). A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3, 579-584.
2. ADAM, M., RAMESH, N., MILLER, D.A., and OSBORNE, W.R.A. (1991). Internal initiation of translation in retroviral vectors carrying picornavirus 5′ nontranslated regions. J. Virol. 65, 4985-4990.
3. ALAMEDDINE, H.S., QUANTIN, B., CARTAUD, A., DEHAUPAS, M., MANDEL, J.L., and FARDEAU, M. (1994). Expression of a recombinant dystrophin in mdx mice using adenovirus vector. Neuromusc. Disord. 4, 193-203.
4. BUSHELL, A., PEARSON, T.C., MORRIS, P.J., and WOOD, K.J. (1995). Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Transplantation 59, 1367-1371.
5. COBBOLD, S., MARTIN, G., and WALDMANN, H. (1986). Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo. Transplantation 42, 239-247.
6. COSIMI, A.B., CONTI, D., DELMONICO, F.L., PREFFER, F.I., WEE, S.L., ROTHLEIN, R., FAANES, R., and COLVIN, R.B. (1990). In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J. Immunol. 144, 4604-4612.
7. COX, K.L., LAWRENCE-MIYASAKI, L.S., GARCIA-KENNEDY, R., LENNETTE, E.T., MARTINEZ, D.M., KRAMS, S.M., BERQUIST, W.E., SO, S.K.S., and ESQUIVEL, C.O. (1995). An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 59, 524-529.
8. DAVIS, H.L., DEMENEIX, B.A., QUANTIN, B., COULOMBE, J., and WHALEN, R.G. (1993). Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene Ther. 4, 733-740.
9. DUNCKLEY, M.G., WELLS, D.J., WALSH, F.S., and DICKSON, G. (1993). Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum. Mol. Genet. 2, 717-723.
10. ENGELHARDT, J.F., LITZKY, L., and WILSON, J.M. (1994a). Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2A. Hum. Gene Ther. 5, 1217-1229.
11. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994b). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory responses in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
12. GINSBERG, H.S., HORSWOOD, R.L., CHANOCK, R.M., and PRINCE, G.A. (1990). Role of early genes in pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 87, 6191-6195.
13. GINSBERG, H.S., MOLDAWER, L.L., SEHGAL, P.B., REDINGTON, M., KILIAN, P.L., CHANOCK, R.M., and PRINCE, G.A. (1991). A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88, 1651-1655.
14. GUÉRETTE, B., ASSELIN, I., VILQUIN, J.T., ROY, R., and TREMBLAY, J.P. (1995). Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Muscle Nerve 18, 39-51.
15. GUSSONI, E., PAVLATH, G.K., LANCTOT, A.M., SHARMA, K., MILLER, R.G., STEINMAN, L., and BLAU, H.M. (1992). Normal dystrophin transcripts detected in DMD patients after myoblast transplantation. Nature 356, 435-438.
16. HADLEY, S., SAMORE, M.H., LEWIS, W.D., JENKINS, R.L., KARCHMER, A.W., and HAMMER, S.M. (1995). Major infection complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation 59, 851-859.
17. HOFFMAN, E.P., BROWN, R.H., and KUNKEL, L.M. (1987). Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-928.
18. HUARD, J., ACSADI, G., JANI, A., MASSIE, B., and KARPATI, G. (1994a). Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 5, 949-958.
19. HUARD, J., VERREAULT, S., ROY, R., TREMBLAY, M., and TREMBLAY, J.P. (1994b). High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J. Clin. Invest. 93, 586-599.
20. JONES, N., and SHENK, T. (1979). Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17, 683-689.
21. KARPATI, G., AJDUKOVIC, D., ARNOLD, D., GLENDHILL, R.B., GUTTMANN, R., HOLLAND, P., KOCH, P.A., SHOUBRIDGE, E., SPENCE, D., VANASSE, M., ATTERS, G.V., ABRAHAMAWIEZ, M., DUFF, C., and WORTON, R.G. (1993). Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol. 34, 8-17.
22. KAY, M.A., HOLTERMAN, A.X., MEUSE, L., GOWN, A., OCHS, H.S., LINSLEY, P.S., and WILSON, C.B. (1995). Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nature Genet. 11, 191-197.
23. KINOSHITA, I., VILQUIN, J.-T., GUERETTE, B., ASSELIN, I., ROY, R., and TREMBLAY, J.P. (1994). Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 17, 1407-1415.
24. LAW, P.K., BERTORINI, T.E., GOODWIN, T.G., CHEN, M., FANG, Q., LI, H.J., and KIRBY, B.S. (1990). Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet 336, 114-115.
25. LENSCHOW, D.J., HO, S.C., SATTAR, H., RHEE, L., GRAY, G., NABAVI, N., HEROLD, K.C., and BLUESTONE, J.A. (1995a). Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181, 1145-1155.
26. LENSCHOW, D.J., ZENG, Y., HATHCOCK, K.S., ZUCKERMAN, L.A., FREEMAN, G., THISTLETHWAITE, J.R., GRAY, G.S., HODES, R.J., and BLUESTONE, J.A. (1995b). Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation 60, 1171-1178.
27. LI, Q., KAY, M.A., FINEGOLD, M., STRATFORD-PERRICAUDET, L.D., and WOO, S.L.C. (1993). Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4, 403-409.
28. LINSLEY, P.S., WALLACE, P.M., JOHNSON, J., GIBSON, M.G., GREENE, J.L., LEDBETTER, J.A., SINGH, C., and TEPPER, M.A. (1992). Immunosuppression in vivo by a soluble form of the CTLA4 T cell activation molecule. Science 257, 792.
29. LOCHMÜLLER, H., PETROF, B.J., ALLEN, C., PRESCOTT, S., MASSIE, B., and KARPATI, G. (1995). Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic (mdx) mice. Biochem. Biophys. Res. Commun. 213, 569-574.
30. MADSEN, J.C., PEUGH, W.N., WOOOD, K.J., and MORRIS, P.J. (1987). The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. Transplantation 44, 849-852.
31. MENDELL, J.R., KISSEL, J.T., AMATO, A.A., KING, W., SIGNORE, L., PRIOR, T.W., SAHENK, Z., BESSON, S., McANDREW, P.E., RICE, R., NAGARAJA, H., STEPHENS, R., LANTRY, L., MORRIS, G.E., and BURGHES, A.H.M. (1995). Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333, 832-838.
32. MICHAELIS, D., GOEBELS, N., and HOHFELD, R. (1993). Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. Am. J. Pathol. 143, 1142-1149.
33. MORGAN, J.E. (1994). Cell and gene therapy in Duchenne muscular dystrophy. Hum. Gene Ther. 5, 165-173.
34. MOULLIER, P., FRIEDLANDER, G., CALISE, D., RONCO, P., PERRICAUDET, M., and FERRY, N. (1994). Adneoviral-mediated gene transfer to renal tubular cells in vivo. Kidney Int. 45, 1220-1225.
35. MUELLER, A.R., PLATZ, K.P., BECHSTEIN, W.O., SCHATTENFROH, N., SOLTENBURG-DIDINGER, G., BLUMHARDT, G., CHRISTE, W., and NEUHAUS, P. (1994). Neurotoxicity after orthotopic liver transplantation: a comparison between cyclosporine and FK506. Transplantation 58, 155-170.
36. NOMOTO, S., FUJIWARA, H., BAN, T., and OHARA, K. (1994). Cardiotoxicity of long-term intravenous administration of FK506 in rabbits: Dose relationship and recovery after discontinuance. Transplant. Proc. 26, 855-857.
37. PARTRIDGE, T.A., MORGAN, J.E., COULTON, G.R., HOFFMAN, E.P., and KUNKEL, L.M. (1989). Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337, 176-179.
38. PAVLATH, G.K., RANDO, T.A., and BLAU, H.M. (1994). Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J. Cell Biol. 127, 1923-1932.
39. PEARSON, C.T., MADSEN, J.C., MORRIS, P.J., and WOOD, K.J. (1990). The induction of transplantation tolerance using donor antigen and CD4 monoclonal antibody. Transplantation Proc 22, 1955-1956.
40. PEARSON, T.C., ALEXANDER, D.Z., WINN, K., LINSLEY, P., LOWERY, R., and LARSEN, C. (1994). Transplantation tolerance induced by CTLA4-Ig. Transplantation 57, 1701-1706.
41. PEARSON, T.C., BUSHELL, A.R., DARBY, C.R., WEST, L.J., MORRIS, P.J., and WOOD, K.J. (1993). Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody. Clin. Exp. Immunol. 92, 211-217.
42. PLATZ, K.P., MUELLER, A.R., BLUMHARDT, G., BACHMANN, S., BECHSTEIN, W.D., KAHL, A., and NEUHAUS, P. (1994). Nephrotoxicity following orthotopic liver transplantation: A comparison between cyclosporine and FK506. Transplantation 58, 170-178.
43. QUANTIN, B., PERRICAUDET, L.D., TAJBAKHSH, S., and MANDEL, J.L. (1992). Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. USA 89, 2581-2584.
44. RAGOT, T., VINCENT, N., CHAFEY, P., VIGNE, E., GILGENKRANTZ, H., COUTON, D., CARTAUD, J., BRIAND, P., KAPLAN, J.-C., PERRICAUDET, M., and KAHN, A. (1993). Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647-650.
45. SETOGUCHI, Y., ARI, H., CHU, C.S., and CRYSTAL, R.G. (1994). Intraperitoneal in vivo gene therapy to delivery α1-antitrypsin to the systemic circulation. Am. J. Respir. Cell Mol. Biol. 10, 369-377.
46. SHIZURU, J.A., GREGORY, A.K., CHAO, C.T., and FATHMAN, C.G. (1987). Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. Science 237, 278-280.
47. SMITH, T.A., MEHAFFEY, M.G., KAYDA, D.B., SAUNDERS, J.M., YEI, S., TRAPNELL, B.C., McCLELLAND, A., and KALEKO, M. (1993). Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet. 5, 397-402.
48. SPERGEL, J.M., HSU, W., AKIRA, S., THIMMAPPAYA, B., KISHIMOTO, T., and CHEN-KIANG, S. (1992). NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A. J. Virol. 66, 1021-1030.
49. STRATFORD-PERRICAUDET, L.D., LEVRERO, M., CHASE, J.F., PERRICAUDET, M., and BRIAND, P. (1990). Evaluation of the transfer and expression in mice of an enzymne-encoding gene using a human adenovirus vector. Hum. Gene Ther. 1, 241-256.
50. TREMBLAY, J.P., MALOUIN, F., ROY, R., HUARD, J., BOUCHARD, J.P., SATOH, A., and RICHARDS, C.L. (1993). Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 2, 99-112.
51. VILQUIN, J.-T., WAGNER, E., KINOSHITA, I., ROY, R., and TREMBLAY, J.P. (1995a). Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J. Cell Biol. 131, 975-989.
52. VILQUIN, J.T., GUÉRETTE, B., KINOSHITA, I., ROY, B., GOULET, M., GRAVEL, C., ROY, R., and TREMBLAY, J.P. (1995b). FK506 immunosuppression to control the immune reactions triggered by first generation adenovirus-mediated gene transfer. Hum. Gene Ther. 6, 1391-1401.
53. VINCENT, N., RAGOT, T., GILGENKRANTZ, H., COUTON, D., CHAFEY, P., GREGOIRE, A., BRIAND, P., KAPLAN, J.-C., KAHN, A., and PERRICAUDET, M. (1993). Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet. 5, 130-134.
54. WALDMANN, H., and COBBOLD, S. (1993). The use of monoclonal antibodies to achieve immunological tolerance. Trends Pharmacol. Sci. 14, 143-148.
55. WALDMANN, H., COBBOLD, S.P., QIN, S., BENJAMIN, R.J., and WISE, M. (1989). Tolerance induction in the adult using monoclonal antibodies to CD4, CD8, and CD11a (LFA-1). Cold Spring Harbor Symp. Quant. Biol. 54, 885-892.
56. WEE, S.L., COSIMI, A.B., ROTHLEIN, R., PREFFER, F.I., FAANES, R., CONTI, D., and COLVIN, R.B. (1991). Functional consequences of anti-ICAM-1 (CD54) in cynomolgus monkeys with renal allografts. Transplantation Proc. 23, 279-280.
57. YANG, Y., NUNES, A.F., BERENCSI, K., FURTH, E.E,. GÖNCZÖL, E., and WILSON, J.M. (1994a). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-441.
58. YANG, Y., NUNES, F.A., BERENCSI, K., GÖNCZÖL, E., ENGELHARDT, J.F., and WILSON, J.M. (1994b). Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7, 362-369.
59. YANG, Y., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with rAecombinant adenoviruses. J. Virol. 69, 2004-2015.